Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Interventions in pulmonary medicine / / Jose Pablo Diaz-Jimenez, Alicia N. Rodriguez, editors
| Interventions in pulmonary medicine / / Jose Pablo Diaz-Jimenez, Alicia N. Rodriguez, editors |
| Edizione | [1st ed. 2013.] |
| Pubbl/distr/stampa | New York, : Springer, 2013 |
| Descrizione fisica | 1 online resource (486 p.) |
| Disciplina | 616.2307545 |
| Altri autori (Persone) |
Diaz-JimenezJose Pablo
RodriguezAlicia N |
| Soggetto topico |
Bronchoscopy
Lungs - Interventional radiology Lungs - Diseases - Diagnosis |
| ISBN |
1-299-33604-3
1-4614-6009-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Foreword -- Section I. Basic endoscopy -- 1. Tracheobronchial Anatomy -- 2. Flexible Bronchoscopy -- 3. Rigid Bronchoscopy -- 4. Anesthesia for Interventional Bronchoscopic Procedures -- 5. Evaluating Outcomes After Interventional Procedures -- 6. Bronchoscopy Education: New Insights -- Section II. Tracheobronchial obstructions -- 7. Reopening The Airway: Fast Methods – Laser Assisted Mechanical Resection, Electrocautery and Argon Plasma Coagulation -- 8. Cryotherapy -- 9. Endobronchial Brachytherapy: Concept, Indications, Technique and Outcomes -- 10. Photodynamic Therapy for Early and Advanced Lung Cancer -- 11. Benign Tracheal And Bronchial Stenosis -- 12. Endobronchial Prosthesis -- Section III. Lung cancer diagnosis -- 13. Early Lung Cancer: Methods For Detection -- 14. Diagnostic Of Lung Cancer: Confocal Bronchoscopy -- 15. Optical Coherence Tomography -- 16. Electromagnetic Navigation -- 17. Lung Cancer Screening and the National Lung Screening Trial (NLST) -- 18. Tissue Acquisition In Patients With Suspected Lung Cancer: Techniques Available to the Pulmonologist -- Section IV. Lung cancer staging -- 19. The New Lung Cancer TNM Classification: Review And Clinical Implications -- 20. Mediastinoscopy And Its Variants -- 21. Endobronchial Ultrasound: Basic Principles -- 22. Endobronchial Ultrasound: Clinical Applications -- Section V. Pleural conditions -- 23. Pleural Anatomy -- 24. Medical Thoracoscopy -- 25. Overview of the Spectrum of Chest Tubes with Focus on the Tunneled Pleural Catheter: Disease Specific Selection -- Section VI. Interventional Bronchoscopy In Asthma And Emphysema -- 26. Endoscopic Methods For Lung Volume Reduction -- 27. Transbroncoscopic Emphysema Treatment with One-way Zephyr Valves -- 28. Endoscopic Lung Volume Reduction for Treatment of Advanced Emphysema Using Injectable Hydrogels -- 29. Bronchial Thermoplasty -- Section VII. Interventional Bronchoscopy In Special Situations -- 30. Percutaneous Tracheostomy -- 31. Bronchoscopy Role In Interstitial Lung Disease -- 32. Endoscopic Foreign Body Removal -- 33. Interventional Pulmonology in the Intensive Care Unit -- Section VIII. Conclusions -- 34. Bronchoscopy and Interventional Pulmonology: Reflections on the Past, the Present, and the Future. |
| Record Nr. | UNINA-9910438127203321 |
| New York, : Springer, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Lung cancer / / edited by Jack A. Roth [and five others]
| Lung cancer / / edited by Jack A. Roth [and five others] |
| Edizione | [Fourth edition.] |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley-Blackwell, , 2014 |
| Descrizione fisica | 1 online resource (634 p.) |
| Disciplina | 616.99/424 |
| Soggetto topico |
Lungs - Diseases - Diagnosis
Lungs - Cancer - Treatment Lungs - Cancer Cancer - Diagnosis |
| ISBN |
1-118-46877-5
1-118-46879-1 1-118-46876-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Lung Cancer; Contents; Contributors; Preface; CHAPTER 1 Smoking Prevention and Cessation; Overview; Introduction; Tobacco and lung cancer; Secondhand smoke andlung cancer; Smoking among lungcancer patients; Forms of tobacco; Smoked tobacco; Smokeless tobacco; Recent developments on the tobacco market; Factors explaining tobacco use; Smoking initiation; Smoking prevention; Nicotine addiction; Benefits of quitting; Smoking cessation interventions; Behavioral counseling; Pharmaceutical aids for smoking cessation; Nicotine replacement therapy; Sustained-release bupropion; Varenicline
Combination therapyUse of medications in pregnancy; Summary; References; CHAPTER 2 Lung Cancer Susceptibility and Risk Assessment Models; Introduction; Epidemiologic risk factors; Family history; Prior inflammatory diseases and disorders; Diet and nutritional risk factors; Genetic susceptibility; Candidate gene approaches; Genome-wide association studies; 6p21 and 12p13; Intermediate phenotypic assays in measuring genetic susceptibility; DNA damage and repair phenotypic assays; Cell cycle phenotypic assays; Phenotypic assays in apoptotic pathways Emerging novel biomarkers for LC risk and early detectionLC risk assessment models; An overview of cancer risk prediction models; Concluding remarks; References; CHAPTER 3 Molecular Profiling; Introduction; Techniques used in molecular profiling; DNA sequencing; RNA profiling; Proteomics; Data analysis and statistics; Clinical applications; Early detection and diagnosis; Molecular subclassification and staging; Selection of therapy; Future directions and conclusions; Acknowledgments; References; CHAPTER 4 Somatic Genome Alterations in Human Lung Cancers; Lung cancer genetics overview Lung adenocarcinoma genomicsMolecular alteration spectra of lung adenocarcinoma; Key genetic alterations in lung adenocarcinoma in a few selected pathways; Genetic correlates of sensitivity and resistance; Germline predisposition; Future directions; Lung squamous cell carcinoma genomics; Introduction and overview of genomic alterations of lung SqCCs; Somatic copy number alterations; Genomic features of small cell lung cancers; Previous molecular findings in SCLC; Large-scale genome analysis studies of SCLC; Biological and clinical implications of SCLC genome alterations; References CHAPTER 5 Serum Proteomic BiomarkersNatural history of lung cancer progression and potential utility for biomarkers in the clinic; The blood proteome; Proteomic discovery platforms; Proteomic approaches for discovery and validation of blood biomarkers; MALDI-TOF MS serum analysis for diagnosis; Serum proteomics for response to therapy; Strategies to address serum proteome complexity; Liquid chromatography (LC) tandem mass spectrometry (MS/MS); Targeted proteomics using multiple reaction monitoring (LC MRM MS); Bio-analytical validation of serum protein biomarkers; Circulating autoantibodies Clinical validation of serum biomarkers |
| Record Nr. | UNINA-9910132216103321 |
| Hoboken, New Jersey : , : Wiley-Blackwell, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Lung cancer / / edited by Jack A. Roth [and five others]
| Lung cancer / / edited by Jack A. Roth [and five others] |
| Edizione | [Fourth edition.] |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley-Blackwell, , 2014 |
| Descrizione fisica | 1 online resource (634 p.) |
| Disciplina | 616.99/424 |
| Soggetto topico |
Lungs - Diseases - Diagnosis
Lungs - Cancer - Treatment Lungs - Cancer Cancer - Diagnosis |
| ISBN |
1-118-46877-5
1-118-46879-1 1-118-46876-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Lung Cancer; Contents; Contributors; Preface; CHAPTER 1 Smoking Prevention and Cessation; Overview; Introduction; Tobacco and lung cancer; Secondhand smoke andlung cancer; Smoking among lungcancer patients; Forms of tobacco; Smoked tobacco; Smokeless tobacco; Recent developments on the tobacco market; Factors explaining tobacco use; Smoking initiation; Smoking prevention; Nicotine addiction; Benefits of quitting; Smoking cessation interventions; Behavioral counseling; Pharmaceutical aids for smoking cessation; Nicotine replacement therapy; Sustained-release bupropion; Varenicline
Combination therapyUse of medications in pregnancy; Summary; References; CHAPTER 2 Lung Cancer Susceptibility and Risk Assessment Models; Introduction; Epidemiologic risk factors; Family history; Prior inflammatory diseases and disorders; Diet and nutritional risk factors; Genetic susceptibility; Candidate gene approaches; Genome-wide association studies; 6p21 and 12p13; Intermediate phenotypic assays in measuring genetic susceptibility; DNA damage and repair phenotypic assays; Cell cycle phenotypic assays; Phenotypic assays in apoptotic pathways Emerging novel biomarkers for LC risk and early detectionLC risk assessment models; An overview of cancer risk prediction models; Concluding remarks; References; CHAPTER 3 Molecular Profiling; Introduction; Techniques used in molecular profiling; DNA sequencing; RNA profiling; Proteomics; Data analysis and statistics; Clinical applications; Early detection and diagnosis; Molecular subclassification and staging; Selection of therapy; Future directions and conclusions; Acknowledgments; References; CHAPTER 4 Somatic Genome Alterations in Human Lung Cancers; Lung cancer genetics overview Lung adenocarcinoma genomicsMolecular alteration spectra of lung adenocarcinoma; Key genetic alterations in lung adenocarcinoma in a few selected pathways; Genetic correlates of sensitivity and resistance; Germline predisposition; Future directions; Lung squamous cell carcinoma genomics; Introduction and overview of genomic alterations of lung SqCCs; Somatic copy number alterations; Genomic features of small cell lung cancers; Previous molecular findings in SCLC; Large-scale genome analysis studies of SCLC; Biological and clinical implications of SCLC genome alterations; References CHAPTER 5 Serum Proteomic BiomarkersNatural history of lung cancer progression and potential utility for biomarkers in the clinic; The blood proteome; Proteomic discovery platforms; Proteomic approaches for discovery and validation of blood biomarkers; MALDI-TOF MS serum analysis for diagnosis; Serum proteomics for response to therapy; Strategies to address serum proteome complexity; Liquid chromatography (LC) tandem mass spectrometry (MS/MS); Targeted proteomics using multiple reaction monitoring (LC MRM MS); Bio-analytical validation of serum protein biomarkers; Circulating autoantibodies Clinical validation of serum biomarkers |
| Record Nr. | UNINA-9910818491303321 |
| Hoboken, New Jersey : , : Wiley-Blackwell, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Maximize your spirometry screening and surveillance resources [[electronic resource]]
| Maximize your spirometry screening and surveillance resources [[electronic resource]] |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Dept. of Labor, Occupational Safety and Health Administration : , : U.S. Dept. of Health and Human Services, Centers for Disease Control, National Institute for Occupational Safety and Health, , [2011] |
| Descrizione fisica | 1 online resource (2 unnumbered pages) : color illustrations |
| Collana |
DHHS (NIOSH) publication
OSHA-NIOSH infosheet |
| Soggetto topico |
Lungs - Diseases - Diagnosis
Pulmonary function tests Spirometry |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910700583903321 |
Der Pneumologe
| Der Pneumologe |
| Pubbl/distr/stampa | Heidelberg, : Springer-Verlag, ©2004- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.24 |
| Soggetto topico |
Lungs - Diseases
Lungs - Diseases - Diagnosis Lungs - Diseases - Treatment Lung Diseases |
| Soggetto genere / forma |
Electronic journals.
Periodical Periodicals. |
| Soggetto non controllato | Respiratory System Diseases |
| ISSN | 1613-6055 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | ger |
| Record Nr. | UNINA-9910143350903321 |
| Heidelberg, : Springer-Verlag, ©2004- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Der Pneumologe
| Der Pneumologe |
| Pubbl/distr/stampa | Heidelberg, : Springer-Verlag, ©2004- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.24 |
| Soggetto topico |
Lungs - Diseases
Lungs - Diseases - Diagnosis Lungs - Diseases - Treatment Lung Diseases |
| Soggetto genere / forma |
Periodical
Periodicals. |
| Soggetto non controllato | Respiratory System Diseases |
| ISSN | 1613-6055 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | ger |
| Record Nr. | UNISA-996203731803316 |
| Heidelberg, : Springer-Verlag, ©2004- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Practical lung pathology : frequently asked questions / / edited by Haodong Xu, Robert W. Ricciotti, Jose G. Mantilla
| Practical lung pathology : frequently asked questions / / edited by Haodong Xu, Robert W. Ricciotti, Jose G. Mantilla |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (354 pages) |
| Disciplina | 262 |
| Collana | Practical Anatomic Pathology |
| Soggetto topico | Lungs - Diseases - Diagnosis |
| ISBN | 3-031-14402-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Aim and Scope -- Preface -- Contents -- Part I: Neoplastic Lung Pathology -- 1: Bronchial Squamous Cell Papilloma Versus Squamous Cell Carcinoma -- Case Presentation -- Pathologic Diagnosis: Bronchial Squamous Cell Papilloma-Negative for Severe Dysplasia and Malignancy -- Key Points -- What Is the Differential Diagnosis for Bronchial Squamous Cell Papilloma? -- How Do I Differentiate Bronchial Squamous Cell Papilloma from Papillary Squamous Cell Carcinoma? -- Are Bronchial Squamous Papilloma and Squamous Cell Carcinoma Associated with Viral Infection? -- Are There Radiographic Differences Between Bronchial Squamous Cell Papilloma and Papillary Squamous Cell Carcinoma? -- What Are the Clinical and Epidemiologic Differences Between Bronchial Squamous Papillomas and Primary Lung Squamous Cell Carcinomas? -- References -- 2: Pulmonary Hamartoma Versus Chondroid Neoplasms -- Case Presentation -- Pathologic Diagnosis: Pulmonary Hamartoma -- What Is the Definition of a Pulmonary Hamartoma? What Are Its Clinical and Prognostic Features? -- What Are the Radiographic Features of Pulmonary Hamartomas? -- What Are the Pathologic Features of Pulmonary Hamartomas? -- What Is the Differential Diagnosis for Pulmonary Hamartomas? -- How Does One Differentiate a Predominately Chondroid Pulmonary Hamartoma from a Chondroid Neoplasm? -- Are Either Chondromas or Pulmonary Hamartomas Associated with Other Conditions? -- Are There Demographic Differences Between Patients with Pulmonary Chondroma and Patients with Hamartoma? -- How Does One Differentiate Pulmonary Hamartoma from Chondrosarcoma? -- References -- 3: Reactive Type II Pneumocyte Hyperplasia Versus Adenocarcinoma -- Case Presentation -- Final Pathologic Diagnosis: Reactive Type II Pneumocyte Hyperplasia in the Wedge Biopsy.
Differentiation Features of Reactive Type II Pneumocyte Hyperplasia and Adenocarcinoma -- Reactive Type II Pneumocyte Hyperplasia -- Cytomorphology -- Secondary Architectures -- The Underlying Lung Injury, Background Stroma, and Inflammatory Cell Infiltrates -- Ancillary Studies -- References -- 4: Atypical Adenomatous Hyperplasia Versus Peribronchiolar Metaplasia -- Case Presentation -- Pathologic Diagnosis: Minimally Invasive Adenocarcinoma, Acinar Pattern with Associated Lepidic Component in the Right Middle Lobe, Multifocal Adenocarcinoma In Situ, and Atypical Adenomatous Hyperplasia (AAH) in the Right Lower Lobe -- What Are the Radiographic Features of Atypical Adenomatous Hyperplasia, and How Do They Differ from Peribronchiolar Metaplasia? -- What Are the Gross Pathologic Features of Atypical Adenomatous Hyperplasia and Peribronchiolar Metaplasia, and in What Gross Context Are They Found? -- What Are the Microscopic Features of Atypical Adenomatous Hyperplasia and Peribronchiolar Metaplasia? Is Immunohistochemistry or Molecular Testing Useful to Distinguish these Entities from One Another? -- References -- 5: Adenocarcinoma In Situ Versus Atypical Adenomatous Hyperplasia -- Case 1 -- Clinical Presentation -- Imaging Studies -- Pathologic Findings -- Gross Examination -- Histologic Examination -- Final Diagnosis: Adenocarcinoma in Situ (AIS) -- Case 2 -- Clinical Presentation -- Imaging -- Pathology -- Gross Examination -- Histology -- Final Diagnosis: Invasive Adenocarcinoma, Acinar Pattern Predominant, with Synchronous Foci of Atypical Adenomatous Hyperplasia (AAH) -- Key Points for Differentiating AIS from AAH -- What Is the Definition of AIS? -- What Is the Definition of AAH? -- What Is the Relationship Between AAH and AIS? -- How Can Radiologic Features Help Distinguish AAH and AIS?. What Is the Difference in Prognosis Between AAH and AIS? -- References -- 6: Invasive Adenocarcinoma Versus Adenocarcinoma In Situ -- Case Presentation -- Pathologic Diagnosis: Invasive Lung Adenocarcinoma, Acinar Predominant -- What Are the Clinical and Prognostic features of Lung Adenocarcinoma? -- What Are the Radiologic Features of Lung Adenocarcinoma? -- What Are the Pathologic Features of Lung Adenocarcinoma? -- How Are Special Stains and Immunohistochemistry Used in the Diagnosis of Lung Adenocarcinoma? How About Genetic/Molecular Findings? -- What Are the Diagnostic Criteria for Adenocarcinoma In Situ (AIS), Minimally Invasive Adenocarcinoma (MIA), and Invasive Adenocarcinoma? -- How Is "Invasion" Defined in Invasive Lung Adenocarcinoma? -- What Is the Prognosis for Adenocarcinoma In Situ (AIS) and Minimally Invasive Adenocarcinoma (MIA) Versus Invasive Adenocarcinoma? -- What Percentage of Resected Lung Adenocarcinomas Are Classified as Adenocarcinoma In Situ (AIS) and Minimally Invasive Adenocarcinoma (MIA) Versus Invasive Adenocarcinoma? -- How Does Tumor Size Play a Role in the Staging of Lung Adenocarcinoma According to the Eighth Edition AJCC Staging Manual? -- What Does Lepidic Pattern Look like? Where Does the Word "Lepidic" Come from? -- How Are Acinar, Solid, Papillary, and Micropapillary Patterns of Lung Adenocarcinoma Defined? -- How Does One Approach a Small Biopsy Specimen that Shows Only Non-mucinous adenocarcinoma with Lepidic Growth Pattern? -- How Does One Approach a Case with Multiple Lepidic-Predominant Lesions, for Example, a Lobectomy Specimen with Multiple Discrete Foci of Lepidic-Prominent Adenocarcinoma, Minimally Invasive Adenocarcinoma, and Adenocarcinoma In Situ? -- What Is the Differential Diagnosis for Lung Adenocarcinoma? -- References. 7: Solid Pulmonary Adenocarcinoma Versus Large-Cell Undifferentiated Carcinoma -- Case Presentation -- Final Diagnosis: Solid-Type Pulmonary Adenocarcinoma -- What Are the Clinical and Prognostic Features of Solid-Type Pulmonary Adenocarcinoma (SPA), and How Do They Differ from Large-Cell Undifferentiated Carcinoma (LCUC)? -- Can Radiologic Studies Be Used to Distinguish SPA from LCUC? -- What Are the Pathologic Features of SPA and LCUC? How Can Special Stains Be Used to Distinguish These Two Entities? -- Are Genetic/Molecular Findings Useful in the Diagnosis and Treatment of SPA and LCUC? -- References -- 8: Large-Cell Neuroendocrine Carcinoma Versus Solid-Predominant Lung Adenocarcinoma -- Case Presentation -- Diagnosis: Large-Cell Neuroendocrine Carcinoma (LCNEC) -- What Are the Key Clinicopathologic Findings of LCNEC and Solid Adenocarcinoma of the Lung? -- Are There any Features on Radiologic Imaging that Would Help Diagnose and Differentiate LCNEC and Solid-Predominant Adenocarcinoma? -- What Immunohistochemical Stains Are Helpful for Diagnosing and Differentiating These Two Entities, Particularly on Small Biopsy/Cytology Specimens? -- Are There any Diagnostic Pitfalls with Immunohistochemistry to Be Aware of? -- What Are Genetic Differences, and Is There any Impact on Therapy? -- References -- 9: Poorly Differentiated Squamous Cell Carcinoma Versus Solid Pattern Adenocarcinoma -- Case Presentation -- Pathologic Diagnosis: Poorly Differentiated Squamous Cell Carcinoma -- What Are the Histopathologic Features of Lung Adenocarcinoma and Squamous Cell Carcinoma? -- What Are the Immunohistochemical Stains Often Utilized to Differentiate Poorly Differentiated Lung Squamous Cell Carcinoma from Solid Adenocarcinoma? -- What Are the Differences in the Prognosis and Molecular Findings between Lung Squamous Cell Carcinoma and Adenocarcinoma?. References -- 10: Invasive Mucinous Adenocarcinoma Versus Ciliated Muconodular Papillary Tumor -- Case Presentation -- Final Diagnosis: Invasive Mucinous Adenocarcinoma (IMA) of the Lung -- What Are the Clinical and Prognostic Features of IMA, and how Do they Differ from Ciliated Muconodular Papillary Tumor (CMPT)? -- How Can Radiologic Studies Be Used to Distinguish IMA from CMPT? -- What Are the Pathologic Features of IMA and CPMT? How Can Immunohistochemistry Be Used to Distinguish these Two Entities? -- Are Genetic/Molecular Findings Different Between IMA and CMPT? -- How to Differentiate IMA from Colloid Adenocarcinoma or Mucinous Adenocarcinoma Metastatic to the Lung? -- How to Diagnose a Tumor with Mixed Morphologic Features of IMA and Invasive Nonmucinous Adenocarcinoma? -- References -- 11: Mucoepidermoid Carcinoma Versus Adenosquamous Carcinoma -- Case Presentation -- Final Diagnosis: Mucoepidermoid Carcinoma, Low Grade -- What Is Mucoepidermoid Carcinoma? -- How Common Is Bronchopulmonary Mucoepidermoid Carcinoma? -- How Do Patients with Bronchopulmonary Mucoepidermoid Carcinoma Present? -- When Should I Consider Mucoepidermoid Carcinoma in the Differential Diagnosis? -- What Ancillary Studies Are Helpful to Establish a Diagnosis of Mucoepidermoid Carcinoma? -- How Are Bronchopulmonary Mucoepidermoid Carcinomas Graded? -- How Do I Distinguish High-Grade Mucoepidermoid Carcinoma from Adenosquamous Carcinoma? -- Do I Need to See Three Cell Populations to Suggest a Diagnosis of Mucoepidermoid Carcinoma? -- References -- 12: Large-Cell (Undifferentiated) Carcinoma (LCC) Versus Large-Cell Neuroendocrine Carcinoma (LCNEC) -- Case Presentation 1 -- Case Presentation 2 -- What Are the Diagnostic Definitions of LCC and LCNEC? -- What Are the Clinical and Prognostic Features of LCC, and How Do they Differ from LCNEC?. How Has Molecular Genetics Played a Role in Defining LCNEC and LCC?. |
| Record Nr. | UNINA-9910631077703321 |
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Practical pulmonary pathology : a diagnostic approach / / [edited by] Kevin O. Leslie, Mark R. Wick
| Practical pulmonary pathology : a diagnostic approach / / [edited by] Kevin O. Leslie, Mark R. Wick |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Philadelphia, PA : , : Elsevier, , [2018] |
| Descrizione fisica | 1 online resource (938 pages) : illustrations (chiefly color) |
| Disciplina | 616.2/4075 |
| Altri autori (Persone) | LeslieKevin O |
| Collana | Pattern recognition series |
| Soggetto topico |
Lungs - Cytopathology
Lungs - Histopathology Lungs - Diseases - Diagnosis Lung - pathology Lung Diseases - diagnosis |
| ISBN | 0-323-44288-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Lung anatomy / Kevin O. Leslie and Mark R. Wick -- Pulmonary function testing for pathologists / Imre Noth -- Optimal Processing of diagnostic lung specimens / Staci Beamer, Dawn E. Jaroszewski, Robert W. Viggiano, and Maxwell L. Smith -- Computed tomography of diffuse lung diseases and solitary ulmonary nodules / Giorgia Dalpiaz -- Developmental and pediatric lung disease / Megan K. Dishop -- Acute lung injury / Oi-Yee Cheung, Paolo Graziano, and Maxwell L. Smith -- Lung infections / Ann E. McCullough and Kevin O. Leslie -- Chronic diffuse lung diseases / Mikiko Hashisako, Junya Fukuoka, and Maxwell L. Smith -- Nonneoplastic pathology of the large and small airways / Mattia Barbareschi and Alberto Cavazza -- Pneumoconioses / Kelly J. Butnor and Victor L. Roggli -- Pulmonary vasculitis and pulmonary hemorrhage / William David Travis, Kevin O. Leslie, and Mary Beth Beasley -- Pulmonary hypertension / Andrew Churg and Joanne L. Wright -- Pathology of lung transplantation / Andras Khoor -- Neuroendocrine neoplasms of the lung / Alain C. Borczuk -- Sarcomas and sarcomatoid neoplasms of the lungs and pleural surfaces / Mark R. Wick, Kevin O. Leslie, and Mark H. Stoler -- Hematolymphoid disorders / Madeleine D. Kraus and Mark R. Wick -- Nonneuroendocrine carcinomas (excluding "sarcomatoid" carcinoma) and salivary gland analogue tumors of the lung / Philip T. Cagle and Timothy C. Allen -- Metastatic tumors in the lung : a practical approach to diagnosis / Stephen Spencer Raab -- Pseudoneoplastic lesions of the lungs and pleural surfaces / Mark R. Wick, Timothy C. Allen, Jon H. Ritter, and Osamu Matsubara -- Benign and borderline tumors of the lungs and pleura / Mark R. Wick and Stacey E. Mills -- Malignant and borderline mesothelial tumors of the pleura / Mark R. Wick, Kevin O. Leslie, Jon H. Ritter, and Stacey E. Mills. |
| Record Nr. | UNINA-9910583021303321 |
| Philadelphia, PA : , : Elsevier, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Protect yourself [[electronic resource] ] : spirometry breathing test
| Protect yourself [[electronic resource] ] : spirometry breathing test |
| Pubbl/distr/stampa | [Cinicnnati, Ohio] : , : U.S. Dept. of Labor, Occupational Safety and Health Administration : , : U.S. Dept. of Health and Human Services, Centers for Disease Control, National Institute for Occupational Safety and Health, , 2011 |
| Descrizione fisica | 1 online resource (1 unnumbered page) : color illustrations |
| Collana | DHHS (NIOSH) publication |
| Soggetto topico |
Lungs - Diseases - Diagnosis
Lungs - Diseases - Prevention Pulmonary function tests Spirometry |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Protect yourself |
| Record Nr. | UNINA-9910700583803321 |
| [Cinicnnati, Ohio] : , : U.S. Dept. of Labor, Occupational Safety and Health Administration : , : U.S. Dept. of Health and Human Services, Centers for Disease Control, National Institute for Occupational Safety and Health, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pulmonary pathology / / Rosane Duarte Achcar, Steve D. Groshong, Carlyne D. Cool
| Pulmonary pathology / / Rosane Duarte Achcar, Steve D. Groshong, Carlyne D. Cool |
| Autore | Duarte Achcar Rosane |
| Pubbl/distr/stampa | Philadelphia, Pennsylvania : , : Wolters Kluwer, , 2017 |
| Descrizione fisica | 1 online resource (641 pages) : color illustrations |
| Disciplina | 617.542044 |
| Collana | Differential Diagnoses in Surgical Pathology |
| Soggetto topico |
Lungs - Pathophysiology
Lungs - Diseases - Diagnosis |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-4963-6014-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910494625803321 |
Duarte Achcar Rosane
|
||
| Philadelphia, Pennsylvania : , : Wolters Kluwer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
